IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research
Toxicologic Pathology · 2025-02 · 53 (2) · 230-233
DOI: 10.1177/01926233241303906 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 12.12.2024. Verfasst von Thomas Steger-Hartmann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Bayer AG, Pharmaceuticals, Berlin, Germany. Hauptthemen laut MEDLINE: Toxicology, Toxicity Tests, Control Groups. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 7 Literaturangaben. Gefördert von: Innovative Health Initiative.
Abstract (Originalsprache)
The virtual control group (VCG) concept was originally developed in the IMI2 project eTRANSAFE, using data of control animals which pharmaceutical companies have accrued over decades from animal toxicity studies. This control data could be repurposed to create virtual control animals to reduce or replace concurrent controls in animal studies. Initial work demonstrated the general feasibility of the VCG concept, but implementation requires significant further collaborative efforts. The new Innovative Health Initiative (IHI) project VICT3R aims to address these challenges and to obtain regulatory acceptance for the VCG concept. To achieve these goals, VICT3R will build a database comprising high-quality, standardized, and duly annotated control animal data from past and forthcoming toxicity studies. The VICT3R project will create workflows and computational tools to generate adequate VCGs based on statistical and artificial intelligence (AI) approaches. The validity, reproducibility, and robustness of the resulting VCGs will be assessed by comparing the performance of their use with that of real control groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bayer AG, Pharmaceuticals, Berlin, Germany.
- Universitat Pompeu Fabra, Hospital del Mar Research Institue, Barcelona, Spain.
- Merck Healthcare KGaA, Darmstadt, Germany.
- SYNAPSE Research Management Partners SL, Madrid, Spain.
ORCID-Profile: Thomas Steger-Hartmann, Ferran Sanz, Frank Bringezu, Inari Soininen
Förderung
- Innovative Health Initiative
Zitieren
APA
Steger-Hartmann, T., Sanz, F., Bringezu, F., & Soininen, I. (2025). IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research. Toxicologic Pathology, 53(2), 230-233. https://doi.org/10.1177/01926233241303906
Vancouver
Steger-Hartmann T, Sanz F, Bringezu F, Soininen I. IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research. Toxicologic Pathology. 2025;53(2):230-233. doi:10.1177/01926233241303906
BibTeX
@article{StegerHartmann2025,
author = {Steger-Hartmann, Thomas and Sanz, Ferran and Bringezu, Frank and Soininen, Inari},
title = {IHI VICT3R: Developing and Implementing Virtual Control Groups to Reduce Animal Use in Toxicology Research},
journal = {Toxicologic Pathology},
year = {2025},
volume = {53},
number = {2},
pages = {230--233},
doi = {10.1177/01926233241303906}
}
EUVIMED